DPX-BRAF

N/A

Report date: 2025/01/26 17:21:27

Base Information

Drug NameDPX-BRAF
Drug Alias NameDPX-BRAF
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionSerine/threonine-protein kinase B-raf modulators
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Wistar Institute Of Anatomy And Biology
China Registration ClassN/A

Develop Information

Active CompaniesThe Wistar Institute Of Anatomy And BiologyIMV Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A